SBI-993
SBI-993 is a SBI-477 analog with improved potency and suitable pharmacokinetic properties for in vivo bioavailability. SBI-993 stimulates insulin signaling by deactivating the transcription factor MondoA[1].
Product Specifications
CAS Number
[2073059-82-0]
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/sbi-993.html
Concentration
10mM
Purity
98.67
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1=NC(C2=CC=C(OC)C=C2)=CS1)C3=CC=C(NCC(N4CCOCC4)=O)C=C3
Molecular Formula
C23H24N4O4S
Molecular Weight
452.53
References & Citations
[1]Byungyong Ahn, et al. MondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling. J Clin Invest. 2016 Sep 1;126 (9) :3567-79.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1170091-01 0.02 mg (E-Coli)
Recombinant Bifidobacterium animalis subsp. lactis Deoxycytidine triphosphate deaminase (dcd)
Ask
View Details MBS1170091-02 0.1 mg (E-Coli)
Recombinant Bifidobacterium animalis subsp. lactis Deoxycytidine triphosphate deaminase (dcd)
Ask
View Details 
MBS1170091-03 0.02 mg (Yeast)
Recombinant Bifidobacterium animalis subsp. lactis Deoxycytidine triphosphate deaminase (dcd)
Ask
View Details